Rockwell Medical (RMTI) Total Current Liabilities (2010 - 2026)
Rockwell Medical's (RMTI) quarterly Total Current Liabilities came in at $9.9 million in Q1 2026, down 11.93% YoY from $11.2 million in Q1 2025, and up 3.01% on a QoQ basis from $9.6 million in Q4 2025.
Rockwell Medical (RMTI) Total Current Liabilities (2010 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 17 years of Total Current Liabilities data on file, last reported at $9.9 million in Q1 2026.
- Quarterly Total Current Liabilities fell 11.93% year-over-year to $9.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.9 million (down 11.93% YoY) and the FY2025 annual result came in at $9.6 million, down 32.01% from the prior year.
- Total Current Liabilities rose to $9.9 million in Q1 2026, from $9.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $21.4 million in Q3 2023 to a low of $9.6 million in Q4 2025.
- A 5-year average of $15.0 million and a median of $14.9 million in 2024 frame the typical range for Total Current Liabilities.
- The widest YoY moves for Total Current Liabilities: up 74.46% in 2022, down 45.55% in 2022.
- Tracing RMTI's Total Current Liabilities over 5 years: stood at $17.7 million in 2022, then fell by 5.96% to $16.6 million in 2023, then declined by 15.3% to $14.1 million in 2024, then tumbled by 32.01% to $9.6 million in 2025, then gained by 3.01% to $9.9 million in 2026.
- The last three Total Current Liabilities figures came in at $9.9 million (Q1 2026), $9.6 million (Q4 2025), and $9.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 11.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.17 Mn |
| Mar 31, 2026 | 9.87 Mn |
| Dec 31, 2025 | 9.58 Mn |
| Sep 30, 2025 | 9.58 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 11.21 Mn |
| Dec 31, 2024 | 14.09 Mn |
| Sep 30, 2024 | 14.18 Mn |
| Jun 30, 2024 | 14.89 Mn |
| Mar 31, 2024 | 14.95 Mn |
| Dec 31, 2023 | 16.64 Mn |
| Sep 30, 2023 | 21.41 Mn |
| Jun 30, 2023 | 17.45 Mn |
| Mar 31, 2023 | 15.07 Mn |
| Dec 31, 2022 | 17.69 Mn |
| Sep 30, 2022 | 19.34 Mn |
| Jun 30, 2022 | 18.54 Mn |
| Mar 31, 2022 | 19.60 Mn |
| Dec 31, 2021 | 20.97 Mn |
| Sep 30, 2021 | 21.76 Mn |